- Home
- MDRR vs PRPO Comparison
MDRR vs PRPO Comparison
Compare MDRR & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- PRPO
- Stock Information
- Founded
- MDRR 2015
- PRPO N/A
- Country
- MDRR United States
- PRPO United States
- Employees
- MDRR N/A
- PRPO N/A
- Industry
- MDRR Real Estate Investment Trusts
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- MDRR Real Estate
- PRPO Industrials
- Exchange
- MDRR Nasdaq
- PRPO Nasdaq
- Market Cap
- MDRR 15.6M
- PRPO 17.1M
- IPO Year
- MDRR 2018
- PRPO N/A
- Fundamental
- Price
- MDRR $11.22
- PRPO $15.75
- Analyst Decision
- MDRR
- PRPO
- Analyst Count
- MDRR 0
- PRPO 0
- Target Price
- MDRR N/A
- PRPO N/A
- AVG Volume (30 Days)
- MDRR 1.9K
- PRPO 16.9K
- Earning Date
- MDRR 08-08-2025
- PRPO 08-12-2025
- Dividend Yield
- MDRR 2.40%
- PRPO N/A
- EPS Growth
- MDRR N/A
- PRPO N/A
- EPS
- MDRR N/A
- PRPO N/A
- Revenue
- MDRR $9,485,128.00
- PRPO $20,029,000.00
- Revenue This Year
- MDRR N/A
- PRPO N/A
- Revenue Next Year
- MDRR N/A
- PRPO N/A
- P/E Ratio
- MDRR N/A
- PRPO N/A
- Revenue Growth
- MDRR N/A
- PRPO 26.67
- 52 Week Low
- MDRR $9.55
- PRPO $3.90
- 52 Week High
- MDRR $15.00
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- MDRR 52.10
- PRPO 76.66
- Support Level
- MDRR $10.09
- PRPO $10.60
- Resistance Level
- MDRR $11.43
- PRPO $11.70
- Average True Range (ATR)
- MDRR 0.45
- PRPO 0.97
- MACD
- MDRR 0.00
- PRPO 0.45
- Stochastic Oscillator
- MDRR 85.57
- PRPO 81.25
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.